European Union - English - EMA (European Medicines Agency)

viatris healthcare limited - tolcapone - parkinson disease - anti-parkinson drugs, other dopaminergic agents - tasmar is indicated in combination with levodopa / benserazide or levodopa / carbidopa for use in patients with levodopa-responsive idiopathic parkinson’s disease and motor fluctuations, who failed to respond to or are intolerant of other catechol-o-methyltransferase (comt) inhibitors.because of the risk of potentially fatal, acute liver injury, tasmar should not be considered as a first-line adjunct therapy to levodopa / benserazide or levodopa / carbidopa.since tasmar should be used only in combination with levodopa / benserazide and levodopa / carbidopa, the prescribing information for these levodopa preparations is also applicable to their concomitant use with tasmar.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fluvoxamine maleate - film coated tablet - 50 milligram - selective serotonin reuptake inhibitors - antidepressants, selective serotonin reuptake inhibitors - it is indicated for depression orobsessive compulsive disorder

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - fluvoxamine maleate - film coated tablet - 100 milligram - selective serotonin reuptake inhibitors - antidepressants, selective serotonin reuptake inhibitors - it is indicated for depression and obsessive compulsive disorder

Malta - English - Medicines Authority

bgp products ltd - dydrogesterone 2.5 mg, estradiol 0.5 mg - film-coated tablet

Malta - English - Medicines Authority

bgp products ltd - hydrochlorothiazide 12.5 mg, eprosartan 600 mg - film-coated tablet

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - propafenone hydrochloride - film coated tablet - 150 milligram - antiarrhythmics, class ic - antiarrhythmics - symptomatic supraventricular tachyarrhythmias requiring treatment, such as av junctional tachycardia, supraventricular tachycardia in patients with wolff-parkinson-white (wpw) syndrome or paroxysmal atrial fibrillation. severe symptomatic ventricular tachyarrhythmia, if the physician considers these to be life-threatening.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - propafenone hydrochloride - film coated tablet - 300 milligram - antiarrhythmics, class ic - antiarrhythmics - symptomatic supraventricular tachyarrhythmias requiring treatment, such as av junctional tachycardias, supraventricular tachycardias in patients with wolff-parkinson-white (wpw) syndrome or paroxysmal atrial fibrillation. severe symptomatic ventricular tachyarrhythmias, if the physician considers these to be life-threatening

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 150 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - pancreatic exocrine deficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 300 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine deficiency.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 400 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency